Pulsed Cytokine Delivery for Anti-Tumor Immunotherapy & its Impact on Toxicity & Efficacy
Time: 12:15 pm
day: Conference Day One
Details:
- Investigating how we can better control the duration and intensity of cytokine signalling to improve therapeutic outcomes
- Exploring the use of intact, killed, non-pathogenic (Decoy) bacteria as a novel approach to induce pulsed cytokine release and anti-tumor activity in pre-clinical models
- Presenting data from a clinical oncology trial demonstrating pulsed and exceptionally broad cytokine induction, designed to improve safety and efficacy
